Viewing Study NCT06592612


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-02-27 @ 1:09 AM
Study NCT ID: NCT06592612
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Oligoprogression View
Keywords: